CompoundingAI

@InvestInMicro We wrote about this today, do give it a read. open.substack.com/pub/compoundin…

Canvas from Europe Paint from Italy Artist from India History on a wall…😎

@dhanesh500 This is not how it works in India. We wrote about this today, do give it a read. open.substack.com/pub/compoundin…

Paintings are one of the most powerful financial instruments in the world used by the ultra rich. Here’s why: > They buy a painting for ₹150 crore > An appraiser values it at ₹500 crore a few years later > They donate it to a museum/charity They don’t get deduction on ₹150 crore, They get deduction on ₹500 crore !! Now add the main layer to this : Many UHNIs don’t even keep the art at home, They store it in “Freeports” in places like Geneva, Singapore or Luxembourg Freeports are tax free warehouses where art can be stored for years without import duty or immediate capital gains tax The artwork can even be sold multiple times while sitting in the same warehouse because technically it never entered the country So the painting doesn’t move, but ownership changes and money moves tax free The elites truly work differently…

@raghavwadhwa We wrote about this today, do give it a real. We would appreciate your opinion on this. open.substack.com/pub/compoundin…

Art is the richest man's tax loophole and nobody talks about it. Until 2007, painting gains in India were completely tax free. Zero. Paintings were "personal effects" under the Income Tax Act. Buy for ₹10 lakh, sell for ₹10 crore, owe nothing. Even today, art is the most opaque asset class in the country. No centralized registry. No mandatory registration of ownership transfers. No stamp duty. No exchange recording the trade. Two collectors can transact ₹100 crore in a living room and no government entity will ever know. Globally, billionaires store art in "freeports" (Geneva, Singapore, Delaware). Paintings sit legally "in transit" for decades. No import duty. No capital gains. No wealth tax. The Geneva freeport alone holds ~1.2 million artworks. The European Parliament literally called them spaces where "trade can be conducted untaxed and ownership concealed." The Poonawallas already own Rembrandt, Van Gogh, Picasso, Renoir, Damien Hirst. This ₹167 crore Raja Ravi Varma is not a painting purchase. It's a wealth strategy disguised as culture.

@bhagatsprithvi True, the data from corporate filings also confirms that.

Tier 2 and Tier 3 cities are seeing massive expansion. Brands like Vishal Mega Mart, Zudio, Domino's Pizza, and other café and food chains are going deeper into these markets, opening large-format stores. They’re setting up big showrooms in smaller cities, driving high footfall, operating on low margins, and relying on fast inventory turnover. It’s a scale game. And it’s crazy how these stores are often more crowded than those in Tier 1 cities.

@apoorvsinghasr Which LLM are you using ? You might want to check these claims.

Saudi Arabia needs 4,000 km of new gas pipeline. The only Indian company inside the gate is Welspun Corp. Read on to understand the thesis! ━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━ WELSPUN CORP LIMITED NSE: WELCORP | BSE: 532144 CMP: ₹846.85 | April 5, 2026 ━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━ The most mispriced infrastructure franchise on the NSE right now. Three countries. Three once-in-a-decade buildouts. One company. Trading at 9.3x FY28 earnings. In May 2026, every screener in India will show a Welspun Corp PAT decline. The algorithms will sell. The Twitter crowd will call it a red flag. Here is what they will all get wrong: FY25 reported PAT of ₹1,900 Cr included a ₹470 Cr one-time gain from a partial EPIC stake sale. That gain will not repeat. Strip it out. Adjusted FY25 operating PAT was ₹1,430 Cr. My FY26 estimate: ₹1,600 Cr adj PAT. That is +11.9% real operating growth. The coming "decline" is a manufactured optical illusion from one non-recurring line item that screeners cannot strip out. That illusion is precisely why this entry window exists at ₹846 today. 📊 Verified Sources: → WCL NSE/BSE Quarterly Filings ✅ → Q3 FY26 Earnings Call Transcript ✅ → CARE Ratings AA+ Reaffirmation Dec 2025 ✅ → CRISIL AA+ Upgrade July 2, 2025 ✅ → Screener.in | Smart-Investing.in ✅ → All forward estimates are personal and independent. Not SEBI registered. Label applies to every number below. ⚠️ NOT SEBI REGISTERED. NOT INVESTMENT ADVICE. DYOR. PURELY EDUCATIONAL. ━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━ 🧱 CHAPTER 1: WHAT THIS COMPANY IS ━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━ Picture three workshops across the planet. One in Anjar, Gujarat. One in Little Rock, Arkansas. One in Dammam, Saudi Arabia. Each workshop takes massive steel coils, bends and welds them into large-diameter pipes, then ships them to oil majors, water utilities, LNG terminal builders, and gas grid operators who have no alternative qualified supplier at that precise specification. That is Welspun Corp. The moat is deceptively simple: API-certified large-diameter pipe manufacturing takes 3 to 5 years and hundreds of crores to build. The new US LSAW mill (end-FY27) will produce pipes from 6 to 56 inches. It will be the ONLY facility in the United States with 56-inch capability. Zero competitors replicate that by FY28. REVENUE SEGMENTS (WCL Filing ✅): → 🇮🇳 India Line Pipes: Oil, LNG, gas transmission. Largest volume segment. → 🇮🇳 Ductile Iron (DI) Pipes: Jal Jeevan Mission water. ~20% EBITDA margin. → 🇺🇸 US Line Pipes: LNG export + AI data centre gas pipelines. Fully booked FY27. → 🇮🇳 TMT Bars: Construction rebar. → 🇮🇳 Stainless Steel Pipes: Defense, BHEL, industrial. Turning profitable FY26. → 🇮🇳 Sintex OPVC: Premium plastic pipes. The consensus calls this a "commodity cyclical." The consensus is wrong. Here is the proof: EBITDA per tonne (CARE Ratings ✅): → FY23 trough: ₹6,577/t → FY24: ₹11,031/t → FY25: ₹11,922/t +81% unit margin expansion in two years while HRC steel prices were FALLING. A commodity business cannot do that. This is a permanent product-mix shift. Every DI tonne adds 700-800 bps of margin over a line pipe tonne. Permanently. ━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━ 📈 CHAPTER 2: THE THREE-ACT STORY ━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━ 🎬 ACT 1 THE STRESS TEST (FY21-FY23): Net debt peaked at ₹3,316 Cr (FY23 ✅). Interest coverage fell to 2.06x (FY23 ✅). Margins at trough: 5.1% EBITDA (CARE ✅). US underutilised. DI not yet at scale. This fear moment permanently discounted the stock into a value trap narrative. 🎬 ACT 2 THE SILENT REBUILD (FY23-FY25): While the market stared at falling revenue, management executed a clear blueprint: → DI capacity India: scaling to 400 KTPA. → EPIC JV: 26.5% Saudi stake established. → US LSAW: new mill planning commenced. → DRI Plant: ₹659 Cr investment launched. → Debt crushed from ₹3,316 Cr to NET CASH. → CRISIL upgraded to AA+ (July 2025 ✅). → ₹1,722 Cr capex deployed in 9M FY26 while staying net cash. Rare discipline. 🎬 ACT 3 THE COMPOUNDING BEGINS (FY26+): Three geographies firing simultaneously. Record order book ₹23,600 Cr in Q3 FY26. ROCE annualised: 24.4% (Earnings Call ✅). US fully booked FY27. Saudi DI commissioning. India LNG + CGD + JJM all running. FCF inflects massively in FY28. The buildout cost is nearly fully deployed. From here, every incremental rupee of capex is maintenance, not construction. ━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━ 🌍 CHAPTER 3: THREE-GEOGRAPHY ENGINE ━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━ 🇮🇳 INDIA: FOUR DEMAND WALLS, ALL RISING → Jal Jeevan Mission: ₹70,000 Cr budget, extended to FY28. DI demand: ~220 KT (FY25) to 400+ KT estimated by FY28. EBITDA ~20% (CARE ✅). → City Gas Distribution: ₹40,000 Cr investment by 2034. (MD, Q3 FY26 Earnings Call ✅) → LNG Terminals: India growing from 52 MTPA to 86 MTPA. Five new terminals by 2030. Every terminal needs high-spec transmission pipe. (MD, Q3 FY26 Earnings Call ✅) → DRI Plant, Anjar Gujarat: 255 KTPA sponge iron. Capex ₹659 Cr. FY27 commissioning. Replaces 15-20% of HRC market purchases permanently. Annual RM savings: ₹150-220 Cr from FY27. 🇺🇸 US: THE AI PIPELINE TRADE MD direct quote, Q3 FY26 Call (verbatim ✅): "We are seeing a significant demand, continuing demand for the pipelines and they are all driven by basically movement for gas pipelines either for LNG export or primarily for data centers. We are seeing a surge of data centers coming up in US and with each data center they have to have their own power plant and all those power plants requires uninterrupted gas for which pipelines are required. So we are into the part of the value chain of the AI data center." → US order book: Fully booked FY27. Partial bookings into FY28. 8 to 9 pipeline projects under active discussion beyond what is already awarded. → New US LSAW Mill, Little Rock (end-FY27): 6 to 56 inch diameter range. ONLY such facility in the United States. No competitor replicates in under 3 years. US premium ASP: USD 800-900/tonne. 🇸🇦 SAUDI: THE LARGEST OPTIONALITY MD direct quote, Q3 FY26 Call (verbatim ✅): "They are contemplating to put almost 4,000 kilometres of new pipeline. Master Gas Phase 4 is about to go to 11.8 bcf per day. From 11.8 bcf to 16.6 bcf per day." → Saudi DI Plant: Commissioning H1 FY26. First local DI manufacturer in Middle East. 2/3 of Saudi DI currently imported. Anti-dumping on DI imports "likely beneficial." (Management, Q3 FY26 ✅) Revenue potential: ₹800-1,200 Cr/yr. → Dammam LSAW MoU (January 2026): 350 KTPA with Saudi Aramco. Converts to contract by Q3 FY27: adds ₹3,500-5,000 Cr revenue from FY28-29. → EPIC JV: 26.5% stake, Tadawul-listed. Recurring JV income + strategic moat. Jaffura gas network + anti-dumping both lift EPIC's forward earnings. → April 2026 geopolitics: Saudi east-west crude bypass expansion post Hormuz tensions = unmodelled incremental pipeline cycle. ━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━ 🔬 CHAPTER 3B: UNIT ECONOMICS MATTER MOST ━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━ The most important number in this thesis is not revenue. Not P/E. Not market cap. It is EBITDA per tonne. Because it tells you whether this is a real business or a volume game dressed up in growth clothes. EBITDA/TONNE TREND (CARE Ratings ✅): → FY23: ₹6,577/t (this was trough fear) → FY24: ₹11,031/t (+67.7%) → FY25: ₹11,922/t (+8.1%) → Q3 FY26: ~₹16,963/t (calc from ₹616 Cr EBITDA / ~363 KT volume) That is +158% unit margin growth in three years, in a so-called commodity. THE MECHANISM: → One India DI pipe tonne earns ~20% EBITDA (CARE ✅) vs ~12-13% for a line pipe tonne. That is +700-800 bps per DI tonne added to the mix. → One US LSAW tonne: USD 800-900/t ASP. At ₹86/USD that is ₹68,800-77,400/t. The margin delta vs India is structural. → DRI from FY27 saves ₹500-800/t on RM cost permanently vs market HRC buyers. These three forces compound together. That is not a cyclical recovery. That is a permanent architecture shift. SENSITIVITY CHECK: → Every ₹1,000/t RM (HRC) change at 1,638 KT FY26 volume: EBITDA impact: ~₹100-120 Cr PAT impact: ~₹70-90 Cr → Forward cover: 2 quarters always held. (Management, Q3 FY26 ✅) P&L lag: 2-3 quarters post spot change. ROIC ON DEPLOYED CAPITAL: → Cumulative capex FY24-FY28: ~₹6,600 Cr → Incremental EBIT by FY28 vs FY24: ~₹1,630 Cr additional EBIT → ROIC = 24.7% vs WACC ~11% (AA+ rated, 0.12x D/E, low risk) → Every rupee invested creates ₹2.25 of enterprise value. Textbook value-creation. ━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━ 💬 CHAPTER 3C: MANAGEMENT QUALITY SCORE ━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━ → Acknowledged misses honestly? YES. JJM sluggishness stated directly. No corporate speak. ✅ → Specific numbered guidance? YES. ₹2,200 Cr EBITDA target. 4,000 km Saudi pipeline quoted. 8-9 active US pipeline discussions. ✅ → Consistent with last quarter guidance? YES. 8 straight quarters of delivery. ✅ → Capital allocation under pressure: ₹1,722 Cr capex in 9M FY26 while staying NET CASH. ✅ → Debt discipline: D/E from 0.70x (FY22) to 0.12x (FY25) during three simultaneous buildouts. ✅ → Credit recognition: Two agencies upgraded to AA+ same year. CRISIL July 2025. CARE December 2025. That does not happen by accident. ✅ → Auditor: Deloitte + MSKA. No change in 3 years. Clean books. ✅ MANAGEMENT CONCALL SCORE: 5/5 ✅ ━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━ 📊 CHAPTER 4: THE VERIFIED NUMBERS ━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━ Q3 FY26 ACTUALS (NSE Filing ✅): → Revenue: ₹4,532 Cr (+25.4% YoY) → EBITDA: ₹616 Cr (+41.7% YoY) → EBITDA Margin: 13.6% vs 12.1% year ago → Adj PAT: ₹365 Cr (+60.3% YoY) 8 STRAIGHT QUARTERS OF EBITDA GROWTH: → Q3 FY25: EBITDA ₹434 Cr | PAT ₹228 Cr → Q4 FY25: EBITDA ₹460 Cr | PAT ₹172 Cr → Q1 FY26: EBITDA ₹525 Cr | PAT ₹300 Cr → Q2 FY26: EBITDA ₹591 Cr | PAT ₹348 Cr → Q3 FY26: EBITDA ₹616 Cr | PAT ₹365 Cr PAT grew ₹228 Cr to ₹365 Cr in 12 months. That is +60%. Compound this forward. OCF QUALITY (Screener.in ✅): → FY24: OCF/PAT = 96% | FY25: 109% → 2-year avg: 102.5%. No earnings tricks. BALANCE SHEET TRANSFORMATION: → Net debt FY23: ₹3,316 Cr → Net debt FY24: ₹820 Cr → Net CASH FY25: ₹340 Cr → Net CASH Q3 FY26: ₹132 Cr ✅ → D/E ratio FY25: 0.12x ✅ → Interest Coverage ~12x annualised ✅ → CRISIL AA+/Stable (Jul 2025 upgrade ✅) → CARE AA+/Stable (Dec 2025 reaffirm ✅) SHAREHOLDING (NSE Dec 2025 ✅): → Promoter: 49.7% | Pledge: 0.0% → FII: 11.5% | DII: 20.6% → Zero pledge for 3 consecutive quarters. ━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━ 🔮 CHAPTER 5: PROJECTIONS All numbers below are personal independent estimates unless labeled ✅ Macro: HRC ₹48K-56K/t, INR/USD ₹86-96, Brent $70-85, 25% tax, JJM extended FY28 ━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━ 9M FY26 base (WCL Filing ✅): → Revenue ₹12,457 Cr | EBITDA ₹1,732 Cr → Adj PAT ₹1,013 Cr FY26E: → Revenue: ₹17,550 Cr (+25.6% YoY) → EBITDA: ₹2,365 Cr | Margin: 13.5% → D&A ₹420 Cr | Interest ₹220 Cr → Other Income (JV+treasury): ₹400 Cr → Adj PAT: ₹1,600 Cr | EPS: ₹60.5 → FCF: ~₹580 Cr | Net Debt: ~₹100 Cr → BV/share: ~₹335 ⚠️ Screener will show PAT "decline" vs FY25 ₹1,900 Cr because FY25 had ₹470 Cr one-time EPIC gain. Adj growth: +11.9%. Screeners lie. This is the entry window. FY27E: (Saudi DI full yr, DRI online H1, US LSAW partial Q4) → Revenue: ₹20,875 Cr (+19.0% YoY) → EBITDA: ₹2,643 Cr | Margin: 12.7% → D&A ₹540 Cr | Interest ₹165 Cr → Other Income: ₹460 Cr → Adj PAT: ₹1,895 Cr | EPS: ₹71.8 → FCF: ~₹790 Cr | Net Debt: ~₹3,000 Cr (US LSAW project finance drawn down) → BV/share: ~₹390 Net Debt/EBITDA: below 1.2x ✅ FY28E: THE INFLECTION YEAR (US LSAW full year 424 KT, capex drops from ₹2,100 Cr to ₹600 Cr, FCF explodes) → Revenue: ₹28,000 Cr (+34.1% YoY) → EBITDA: ₹3,500 Cr | Margin: 12.5% Note: Two independent models (top-down and bottom-up) BOTH arrive at ₹3,500 Cr. That convergence is not coincidence. → D&A ₹615 Cr | Interest ₹195 Cr → Other Income: ₹510 Cr → Adj PAT: ₹2,400 Cr | EPS: ₹90.9 → FCF: ₹2,400 Cr | FCF/share: ₹90.9 → FCF Yield at CMP ₹846.85: 10.7% → Net Cash: ~₹8,500 Cr → BV/share: ~₹479 ₹100 invested today earns ₹10.7 pure free cash annually from FY28. Best AA+ FD pays ₹6.5. WCL grows revenue at 27% CAGR. FY29E: (US LSAW 85%+ util, Saudi LSAW P1, India CGD full swing, DRI full savings) → Revenue: ₹34,000 Cr (+21.4% YoY) → EBITDA: ₹4,420 Cr | Margin: 13.0% → Adj PAT: ₹3,100 Cr | EPS: ₹117.4 → FCF: ~₹3,500 Cr | Net Cash: ~₹13,000 Cr → BV/share: ~₹579 FY30E: (H2/CCUS specs emerging, Saudi P2, India CGD near complete, US wave 2) → Revenue: ₹40,500 Cr (+19.1% YoY) → EBITDA: ₹5,470 Cr | Margin: 13.5% → Adj PAT: ₹3,850 Cr | EPS: ₹145.8 → FCF: ~₹4,500 Cr | Net Cash: ~₹18,500 Cr → BV/share: ~₹690 ━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━ 🎯 CHAPTER 6: UPSIDE CALCULATOR CMP ₹846.85 | 26.4 Cr shares ━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━ PEER CONTEXT: → APL Apollo: ~47x P/E (branded ERW) → Jindal SAW: ~14x P/E (no US/Saudi) → Maharashtra Seamless: ~9.3x P/E → Sector avg P/E: ~22.7x (NSE Apr 2026) → WCL at 11.4x TTM = 50% sector discount P/E formula: Multiple × EPS EV/EBITDA: [(Multiple × EBITDA) ± Net Debt] divided by 26.4 Cr shares P/B: Multiple × BV/share FCF Yield: FCF/share divided by yield % ━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━ 📅 FY26E (EPS ₹60.5 | BV ₹335) ━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━ P/E: 🐂 17x: ₹1,029 (+22%) | Q4 beats guidance ⚖️ 14x: ₹847 (+0%) | In-line delivery 🐻 10x: ₹605 (-29%) | Screener panic EV/EBITDA (Net Debt ₹100 Cr): 🐂 12x: ₹1,071 (+26%) ⚖️ 10x: ₹892 (+5%) 🐻 8x: ₹713 (-16%) P/B: 🐂 3.5x: ₹1,173 (+39%) ⚖️ 3.0x: ₹1,005 (+19%) 🐻 2.0x: ₹670 (-21%) ✅ BASE TP: ₹847-1,005 | BULL: ₹1,029-1,173 Screener dip in May 2026 = entry window. ━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━ 📅 FY27E (EPS ₹71.8 | BV ₹390) ━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━ P/E: 🐂 18x: ₹1,292 (+53%) | Saudi DI + DRI live ⚖️ 15x: ₹1,077 (+27%) | In-line execution 🐻 11x: ₹790 (-7%) | JJM + HRC spike EV/EBITDA (Net Debt ₹3,000 Cr): 🐂 11x: ₹986 (+16%) ⚖️ 9x: ₹786 (-7%) 🐻 7x: ₹586 (-31%) P/B: 🐂 3.5x: ₹1,365 (+61%) ⚖️ 3.0x: ₹1,170 (+38%) 🐻 2.0x: ₹780 (-8%) ✅ PRIMARY ANCHOR: P/E 15x + P/B 3.0x Base TP: ₹1,077-1,170 (+27-38%) EV/EBITDA lower as FY27 is peak capex year. ━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━ 📅 FY28E (EPS ₹90.9 | BV ₹479) FCF ₹90.9/sh | FCF Yield 10.7% 4 METHODS. ALL CONVERGE. ━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━ P/E: 🐂 20x: ₹1,818 (+115%) | US LSAW full util ⚖️ 16x: ₹1,454 (+72%) | FCF confirmed 🐻 12x: ₹1,091 (+29%) | 1 geo underdelivers EV/EBITDA (Net CASH ₹8,500 Cr): 🐂 11x: ₹1,784 (+111%) ⚖️ 9x: ₹1,515 (+79%) 🐻 7x: ₹1,249 (+47%) P/B: 🐂 4.0x: ₹1,916 (+126%) ⚖️ 3.2x: ₹1,533 (+81%) 🐻 2.2x: ₹1,054 (+24%) FCF YIELD: 🐂 5%: ₹1,818 (+115%) ⚖️ 7%: ₹1,299 (+53%) 🐻 10%: ₹909 (+7%) SoTP (FY28E): → India LP: ₹940 Cr × 7.5x = ₹7,050 Cr → DI Pipes: ₹910 Cr × 7.5x = ₹6,825 Cr → US LP: ₹1,070 Cr × 8.0x = ₹8,560 Cr → Saudi LP: ₹120 Cr × 7.0x = ₹840 Cr → SS Pipes: ₹190 Cr × 12.0x = ₹2,280 Cr → TMT Bars: ₹160 Cr × 5.0x = ₹800 Cr → Sintex: ₹90 Cr × 27.5x = ₹2,475 Cr → EPIC JV (26.5%): 12x PAT = ₹2,035 Cr → Total EV: ₹30,865 Cr → + Net Cash: ₹8,500 Cr → Equity: ₹39,365 Cr / 26.4 Cr = ₹1,491/sh 🐂 Bull (Saudi LSAW converts): ₹1,700+ ⚖️ Base: ₹1,491 🐻 Bear (Saudi stays MoU): ₹1,180 ✅ FY28 VERDICT: VERY HIGH CONVICTION All 4 methods converge above ₹1,054. BEAR CASE MINIMUM: +24% to +47%. Net cash ₹8,500 Cr creates a hard floor. ━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━ 📅 FY29E (EPS ₹117.4 | BV ₹579) ━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━ P/E: 🐂 22x: ₹2,583 (+205%) ⚖️ 18x: ₹2,113 (+150%) 🐻 13x: ₹1,526 (+80%) EV/EBITDA (Net Cash ₹13,000 Cr): 🐂 11x: ₹2,338 (+176%) ⚖️ 9x: ₹2,003 (+137%) 🐻 7x: ₹1,667 (+97%) FCF Yield (FCF ₹132.6/sh): 🐂 5%: ₹2,652 (+213%) ⚖️ 7%: ₹1,894 (+124%) 🐻 10%: ₹1,326 (+57%) ✅ BEAR CASE ALONE: +57-97% from CMP. That is what asymmetric opportunity actually looks like on paper. ━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━ 📅 FY30E (EPS ₹145.8 | BV ₹690) ━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━ P/E: 🐂 25x: ₹3,645 (+330%) ⚖️ 20x: ₹2,916 (+244%) 🐻 14x: ₹2,041 (+141%) EV/EBITDA (Net Cash ₹18,500 Cr): 🐂 12x: ₹3,187 (+276%) ⚖️ 9.5x: ₹2,669 (+215%) 🐻 7x: ₹2,151 (+154%) FCF Yield (FCF ₹170.5/sh): 🐂 4%: ₹4,263 (+403%) ⚖️ 6%: ₹2,842 (+235%) 🐻 9%: ₹1,894 (+124%) ✅ BEAR CASE: +124-154%. Not a typo. A 4-year compounding franchise thesis. Not a trade. ━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━ 🕐 WHY RIGHT NOW IS THE ENTRY WINDOW ━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━ Three converging forces create the entry: → FORCE 1: Screener Confusion Incoming May 2026 Q4 results will show PAT "down" vs FY25 because of the ₹470 Cr one-time item last year. Most retail investors will see a red screener and sell. Institutions who can read a cash flow statement will buy. Be on the right side. → FORCE 2: Capex Peak Is Done FY26 capex: ₹2,290 Cr. FY27: ₹2,100 Cr. FY28: ~₹600 Cr. Peak spending is over. FCF goes from ₹580 Cr to ₹2,400 Cr in just 24 months. The FCF machine turns on exactly when the market least expects it. → FORCE 3: Geopolitical Tailwind Unmodelled April 2026: Hormuz tensions accelerate Saudi bypass pipeline construction. Zero sell-side models have this. Zero screeners can model it. You have the MD's own words from Jan 2026. 4,000 km of new pipeline in Saudi Arabia. WCL is inside the gate with a JV and a manufacturing MoU already signed. When the screener crowd sells in May, the geopolitical crowd will be buying. That asymmetry is where you want to be. ━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━ ⚠️ CHAPTER 7: THE HONEST RISK REGISTER ━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━ 🔴 RISK 1: HRC STEEL SPIKE >15% → Trigger: India HRC > ₹60,000/t for 2+ Qs → PAT impact: -₹150-200 Cr/year → Probability: 30% → Monitor: JSW/Tata Steel monthly pricing. Forward cover below 6 weeks = red flag. 🔴 RISK 2: JJM FUNDING SLOWDOWN → Trigger: Fund utilisation <40% for 2+ Qs → PAT impact: -₹200-280 Cr (DI -15-20%) → Probability: 25% → Monitor: jalshakti.gov.in disbursements. 🔴 RISK 3: SAUDI MoU DOES NOT CONVERT → Trigger: Dammam LSAW no formal LOI by Q3 FY27 → PAT impact: -₹120-180 Cr (FY28-29) → Probability: 20% → Monitor: WCL BSE/NSE contract filing. 🔴 RISK 4: MAY 2026 SCREENER PANIC → PAT optic looks like decline = -10-15% → Probability: 75% (near certain) → THIS IS AN ENTRY WINDOW, NOT AN EXIT. → Watch: Q4 EBITDA > ₹560 Cr = thesis on. 🔴 RISK 5: US LSAW YEAR-1 QUALITY FAIL → Trigger: 56-inch batch fails API spec → PAT impact: -₹100-150 Cr (FY28 delay) → Probability: 15% → Monitor: Any NSE warranty/rejection note. ━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━ ⚡ CHAPTER 8: CATALYST CALENDAR ━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━ → MAY 2026 [CRITICAL]: Q4 FY26 results. FY27 guidance issued. Screener panic = buy zone. EBITDA > ₹2,365 Cr FY26 = thesis intact. → APR-JUN 2026 [HIGH]: Saudi DI first production announced. First DI pipe made in Middle East. Anti-dumping ruling outcome. Impact: +₹30-50 on stock price. → JUN-SEP 2026 [HIGH]: Dammam LSAW formal Aramco contract. MoU converts to order = re-rating event. Impact: +₹50-100 on stock price. → Q1-Q2 FY27 [MEDIUM]: DRI plant Anjar first production. First RM cost savings hit the P&L. 50-80 bps margin expansion visible. → Q4 FY27 [VERY HIGH]: US LSAW Little Rock commissioning. Only 6-56 inch mill in United States. Institutional upgrades begin. Impact: +₹100-200 over 2 quarters. ━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━ 🏆 CHAPTER 9: FINAL VERDICT ━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━ Three things the market has missed: 1️⃣ THE MISPRICING IS MANUFACTURED: FY25 had ₹470 Cr one-time EPIC gain. FY26 "decline" is optical, not operational. Adjusted operating PAT grows +11.9%. Screeners lie. Verified cash flows don't. 2️⃣ THE DATA SEALS THE THESIS: EBITDA/tonne: ₹6,577 (FY23) to ₹11,922 (FY25) while HRC prices fell. (CARE ✅) +81% unit margin in a "commodity" business. This is permanent product-mix compounding. 3️⃣ THE NUMBERS MAKE THE CASE: At CMP ₹846.85, my FY28 FCF yield = 10.7%. Better than AA+ fixed deposits in India on a company growing at 27% revenue CAGR. Bear case FY28: +24-47%. Base: +72-81%. THE SINGLE CORE INSIGHT: At 9.3x FY28 earnings, Welspun Corp is priced as a commodity cyclical while quietly building the most strategically positioned large-diameter pipeline franchise across three continents. That gap between price and value is exactly where multi-baggers are born. 📊 RATING: BUY / ACCUMULATE ON DIPS 📊 CONVICTION: HIGH (9/10) 📊 12M TP: ₹1,005-1,170 (+19-38%) 📊 24M TP: ₹1,291-1,454 (+52-72%) 📊 36M TP: ₹1,491-1,818 (+76-115%) 📊 STOP LOSS: ₹680 weekly close ENTRY PLAN: → Tranche 1 (40%): ₹840-870 (now) → Tranche 2 (40%): ₹750-800 (May panic) → Tranche 3 (20%): Breakout above ₹950 → Avg entry: ₹820-855 RISK:REWARD at ₹850 entry: → Downside to SL: -20% → Base 24M upside: +65% → R:R = 3.25:1 RAISES CONVICTION TO 10/10: → Saudi Dammam formal contract filed → FY28 FCF confirmed at ₹2,000 Cr+ actuals → FII ownership crosses 13% FORCES EXIT: → Promoter pledge goes non-zero any quarter → FY27 OCF/PAT drops below 0.5x for 2+ Qs → Saudi LSAW + DI anti-dumping both fail THIS IS NOT A 3-MONTH TRADE. This is a 4-year compounding franchise bet. Three countries. Three once-in-a-decade buildouts. One pipe maker. One price: ₹846. The market will eventually price what this business has become. The question is only whether you are early enough to matter. ━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━ ⚠️ NOT SEBI REGISTERED. NOT INVESTMENT ADVICE. ALL FORWARD ESTIMATES ARE INDEPENDENT PERSONAL PROJECTIONS. VERIFIED DATA LABELED ✅ THROUGHOUT. DYOR BEFORE ANY INVESTMENT DECISION. ━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━ #WelspunCorp ━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━

Despite positive FCF and near-zero debt, Titan Biotech shows early signs of stress: -Operating cash flow is declining (~5%) -Net margins have compressed ~300 bps -ROCE has dropped sharply: 25.18% → 23.91% → 17.01% -Costs (employee + depreciation) are rising much faster than revenue Note : No Buy/Sell Reco. Content for educational purposes.

Every number in this thread came from primary source concall transcripts. 30+ banks and NBFCs. Every claim is cited to the source document and page - not a news article, not a screener export. That's what CompoundingAI does for every result season.

Four things the divergence is telling you that analyst reports aren't: The quality gap is repricing. Kotak vs. IndusInd at 226 bps wasn't this wide a year ago. The market is starting to pay for clean books. NRI risk has no model. A 26% deposit outflow scenario doesn't exist in any sell-side note. It will. Within NBFCs, Bajaj at 0.27% and Shriram at 4.54% are not in the same story. Stop reading them as one. Headline GNPA is now actively misleading. IDFC First's 1.69% is doing real work hiding a 5.00% MFI book. SBI Chairman said it directly: strip out rupee depreciation from the 15% growth number before you read Q4. The underlying is 8.7%.

One banking system. Two completely different credit cycles running inside it. 226 bps separates the best GNPA from the worst and that gap is still widening. Q4 results start April 9. This thread is your cheat sheet.🧵

A quick summary of key corporate announcements from 4th April and 5th April 2026. 1. SRM Contractors - Secures ₹483 Cr infrastructure contract from MSIDC 2. Triton Valves - Wins 7-year TPMS valve contract (₹112 Cr revenue visibility) 3. J Kumar Infraprojects - Bags ₹1,184 Cr Lucknow Exhibition Centre LoA 4. Shreeji Shipping - Appointed mine developer & operator (20-year tenure) 5. Fabtech Technologies - Reports strong global order book (>₹900 Cr) 6. Schaeffler India - Declares final dividend of ₹35/share 7. Lexora Global - Approves restructuring + ₹50 Cr rights issue 8. Sanmit Infra - Approves equity share consolidation (10:1) 9. Himalaya Food Intl - Plans debt settlement & equity conversion (₹43 Cr OTS) 10. Suncity Synthetics - Approves ₹3 Cr preferential issue 11. Meghmani Organics - Approves merger of chemical subsidiaries 12. Sahyadri Industries - Acquires 26% stake in solar business 13. Standard Capital - Divests 100% stake in non-core subsidiary 14. MethodHub Software - Announces US acquisition (NDA signed) 15. Bluspring Enterprises - Sets up Abu Dhabi subsidiary (AED 300K capital) 16. Elitecon Intl - CFO resigns 17. Oscar Global - Major management & board restructuring 18. NDA Securities - Appoints new CEO, reconstitutes board 19. Mercury Trade Links - Leadership reshuffle, new directors onboard 20. Sharpline Broadcast - Appoints new CFO 21. IL&FS Engineering - Reports ₹2,627 Cr debt default 22. EPACK Durable - Receives GST demand (~₹41 lakh) 23. Zydus Wellness - Spanish subsidiary penalized (EUR 19K) 24. Mangalam Global - Settles SEBI proceedings 25. Comp-u-com Software - EPFO dues order (~₹64 lakh) 26. TAI Industries - Promoter group increases stake to 13.13%

We ran through three quarters of headcount, revenue per employee, and margin data across TCS, Infosys, and HCL Tech. Here is the picture that came out. TCS cut 30,906 people from its workforce across Q1-Q3 FY26. Not through attrition alone - this was deliberate pyramid optimization, the CFO said so on the call. In the same three quarters, revenue per employee climbed from $12,107 to $12,901. Margins held at 25.2%. The company also disclosed that 180,000 employees now have higher-order AI skills - double the 80,000 from a year ago. That last number is the mechanism. You don't cut 5% of your workforce while growing revenue per head unless something structural is happening on the productivity side. HCL Tech is the other half of this story, and it is less obvious. Reported margins look like a recovery - 16.3% in Q1, 17.4% in Q2, 18.6% in Q3. But what those numbers don't show is that the company absorbed restructuring charges of 55 bps in Q2 and 81 bps in Q3. Both disclosed one-offs. Both compressing what would otherwise be a cleaner print. Strip those out and HCL Tech's operating trajectory is already inside striking distance of the 19–20% target the management set under Project Ascend. The reported margin understates the actual improvement. That gap closes in Q4 without needing any new revenue growth - just the one-offs normalizing. Infosys is the contrast case and it is instructive. Headcount grew by 13,246 across the same period. Revenue per employee declined quarter-on-quarter in Q3. Margins improved by 40 bps total across three quarters- incremental, not structural. Infosys is not doing anything wrong. They have genuine AI programmes, legitimate skilling initiatives, real efficiency work. But the productivity signal in the numbers is weaker. The workforce is expanding. Output per person is not keeping pace. What this adds up to is a split that most sector coverage is not naming directly. Indian IT is not one cohort moving through the same AI transition at the same speed. TCS and HCL Tech are actively reducing headcount dependency while improving output per person. Infosys is still in an expansion mode with diluted productivity metrics.

TCS reports Thursday (09.04.2026). Four metrics now carry a full year of management commitment behind them. 1) International CC growth. Krithivasan repeated the same commitment across Q1, Q2, and Q3: full-year FY26 international growth must exceed FY25. The FY25 baseline was ~0.7% CC - effectively flat. Q3 sequential international CC growth printed at 0.4%. Q4 needs to close the year above that 0.7% bar. A miss on the final quarter of a three-quarter commitment is not a rounding error. 2) North America. Q2 CC growth: 0.1% QoQ. Q3 CC growth: 0.1% QoQ. Two consecutive quarters of zero meaningful movement in the largest geography. Management characterised it as "sluggish" in Q3 and guided for recovery. Thursday either shows the inflection or confirms the full year closed with North America flat. 3) Operating margin. CFO Seksaria's stated direction: "all efforts to climb towards 26%." Current position: 25.2% for two straight quarters. The margin structure in Q3 showed +80 bps from productivity and pyramid optimisation, offset by -50 bps wage impact and -50 bps brand investment. The levers are visible but the movement is not. Q4 is the last quarter of FY26. 4) AI revenue run-rate. $1.5B annualised at the December Analyst Day. $1.8B by Q3 - a $300M sequential addition at 17.3% QoQ CC growth. The one area where delivery has matched the language. Crossing $2B requires approximately 11% growth from the Q3 level. If that clears Thursday, the scaling argument has two consecutive data points behind it. Three of the four commitments remain undelivered at the full-year line. Contextual result analysis on CompoundingAI within 10 mins of results on 9th April.

@abhymurarka Most of it is AI slop- Would you trust the work of your junior analyst if they come up with a report with made up and inconsistent numbers? It is far from being solved- these numbers are from IndianFin Bench(we will be making it public next week) and claude barely achieves 31%

Over the last few days, have seen tweets on adopting AI for research, example - generating research reports using Claude. Great, but alpha now resides beyond "the level 1 research" and more importantly in your judgement quality. AI is not doing that. The paradigm has shifted.

Many billionaires follow this practice worldwide! Middle class is net taxpayer w.r.t their income!

The more interesting thing is what art does as a financial instrument that almost nothing else can - it has no standardised pricing, no AML obligations on auction houses under India's PMLA, and when it sells publicly, the proceeds are immediately documented, taxable, and clean. Run the hypothetical: acquire privately at ₹40 crore through a dealer, sell publicly five years later at ₹167 crore, pay LTCG at 20% with indexation plus auction fees, walk away with roughly ₹135 crore of fully white capital at an effective conversion cost of around 25%. Or skip the sale entirely - donate the work to a cultural institution, claim a 80G deduction at the auction-anchored fair market value of ₹167 crore, and at a 35% effective tax rate, the deduction alone saves ₹58 crore. On a ₹40 crore acquisition, that's a net positive after tax. The painting ends up in a museum with your name on it. The EU figured this out in 2020 and brought auction houses under full KYC compliance. The US closed the same gap in 2021. India hasn't - which might explain why the Indian art market has grown from $2 million in annual transactions twenty-five years ago to $338 million today, while global art markets are actually contracting.